Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Journal of Clinical Microbiology|March 11, 2011
Comparison of strain typing results for Clostridium difficile isolates from North AmericaFred C Tenover, Thomas Akerlund, Dale N Gerding, et al.
Food Chemistry|October 31, 2012
Influence of sorghum flour addition on flat bread in vitro starch digestibility, antioxidant capacity and consumer acceptabilityAdel Yousif, Dorothy Nhepera, Stuart Johnson
Infectious Disease Clinics of North America|August 21, 2025
Advances in the Medical Treatment of Clostridioides difficile InfectionNirja Mehta, Colleen Kraft, Stuart Johnson
Infection Control and Hospital Epidemiology|June 6, 2015
Clostridium difficile Infection Among Veterans Health Administration PatientsYinong Young-Xu, Jennifer L Kuntz, Dale N Gerding, et al.
Clinical Trials (London, England)|June 22, 2021
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollmentDimitri M Drekonja, Aasma Shaukat, Jane H Zhang, et al.
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Chemical Communications (Cambridge, England)|February 20, 2020
Arylation and alkenylation of activated alkyl halides using sulfonamidesStuart Johnson, Ervin Kovács, Michael F Greaney
Infection Control and Hospital Epidemiology|November 28, 2002
Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospitalJoseph J Pulvirenti, Dale N Gerding, Catherine Nathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
Vaccine|November 28, 2009
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)Brett A Leav, Barbra Blair, Mark Leney, et al.
Pageof 24